THRD
Third Harmonic Bio Inc.Key Statistics
About Third Harmonic Bio Inc.
Third Harmonic Bio Inc. is an innovative biotechnology company dedicated to advancing breakthrough therapies for severe immunological and inflammatory disorders. Utilizing its proprietary genetic engineering platform, the firm is developing a robust pipeline of drug candidates designed to address significant unmet medical needs within the biopharmaceutical sector. With a strong emphasis on scientific rigor and patient-centric solutions, Third Harmonic Bio is strategically positioned to transform treatment paradigms and enhance the quality of care for patients and healthcare providers alike.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-64.25M |
| Operating Margin | 0.00% |
| Return on Equity | -19.90% |
| Return on Assets | -14.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.06 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.09 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $45.13M |
| Float | $15.60M |
| % Insiders | 9.11% |
| % Institutions | 80.12% |
Historical Volatility
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on THRD and any ticker you trade — then tracks every position and per-strategy win rate.